Company: PTPI
Filing Date: 2025-02-10
Form Type: S-1/A
Source: 0001410578-25-000108
Chunk: 243

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-10
Form: S-1/A
Chunk 243
---
                    | ​ | ​    |                              -9,099,230 | ​ | ​    |  -1,153,846 | ​ | ​    |                               -1,974,359 | ​ | ​    |  -1,153,846 |
| ​                                            | ​ | ​    |                                       ​ | ​ | ​    |           ​ | ​ | ​    |                                        ​ | ​ | ​    |           ​ |
| Net loss attributable to common stockholders | ​ |      |                             -16,008,578 | ​ | ​    |  -9,974,416 | ​ | ​    |                               -5,246,715 | ​ | ​    |  -6,042,586 |
| Basic and Diluted                            | ​ | $    |                                   -2.18 | ​ | $    |       -4.73 | ​ | $    |                                    -0.53 | ​ | $    |       -2.85 |
| Weighted average common shares outstanding   | ​ |      |                                       ​ | ​ |      |           ​ | ​ | ​    |                                        ​ | ​ | ​    |           ​ |
| Basic and Diluted                            | ​ |      |                               7,332,030 | ​ | ​    |   2,108,747 | ​ | ​    |                                9,829,793 | ​ | ​    |   2,119,620 |

The accompanying Notes are an integral part of the Unaudited Condensed Consolidated Financial Statements.

F-34

PETROS PHARMACEUTICALS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (Unaudited)

| ​                                                 
 ​                                                 
 ​                                                 
 ​                                                 
 ​                                                 
 ​                                                 
 Three Months Ended September 30, 2024             | ​ 
 ​ 
 ​ 
 ​ 
 ​ |           ​ 
           ​ 
 Convertible 
  Redeemable 
   Preferred 
       Stock 
           ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​           
 Convertible 
 Redeemable  
 Preferred   
 Stock       
 Amount      
 ​           |          ​ 
          ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ |          ​ 
          ​ 
          ​ 
          ​ 
     Common 
      Stock 
          ​ | ​